Shopping Cart
- Remove All
- Your shopping cart is currently empty
Z4P, an IRE1 inhibitor with blood-brain barrier permeability (BBB) (IC50=1.13 μM), inhibits glioblastoma growth and recurrence in combination with Temozolomide.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $74 | In Stock | |
5 mg | $179 | In Stock | |
10 mg | $297 | In Stock | |
25 mg | $596 | In Stock | |
50 mg | $953 | In Stock | |
100 mg | $1,480 | In Stock | |
200 mg | $1,980 | In Stock | |
1 mL x 10 mM (in DMSO) | $198 | In Stock |
Description | Z4P, an IRE1 inhibitor with blood-brain barrier permeability (BBB) (IC50=1.13 μM), inhibits glioblastoma growth and recurrence in combination with Temozolomide. |
In vitro | Z4P inhibits IRE1α RNase activity in GBM cells (U87, RADH87, U251, UTMZ), reducing XBP1s and SPARC expression and showing dose-dependent antiproliferative effects. At 25 μM (48 h), Z4P significantly suppresses GBM cell viability and enhances the efficacy of TMZ[1]. |
In vivo | Z4P crosses the BBB and, at 300 μg/kg i.p. daily for 28 days, significantly reduces tumor size in GBM xenograft mice. Combined with TMZ, Z4P causes near-complete tumor regression with no evident toxicity[1]. |
Alias | Z4-P |
Molecular Weight | 312.41 |
Formula | C19H24N2O2 |
Cas No. | 2361760-87-2 |
Smiles | O=C(NC1=CC(=CC=C1C)C)NC(C)CCC2=CC=C(O)C=C2 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (256.07 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.